pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
asubtela (ethinylestradiol/drospirenon 0,03 mg/3 mg focus) filmuhúðuð tafla 3 mg/ 0,03 mg
exeltis healthcare s.l. - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/ 0,03 mg
norditropin flexpro stungulyf, lausn 5/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 5/1,5 mg/ml
norditropin flexpro stungulyf, lausn 15/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 15/1,5 mg/ml
norditropin flexpro stungulyf, lausn 10/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 10/1,5 mg/ml
reseligo (goserelin alvogen) vefjalyf í áfylltri sprautu 10,8 mg
zentiva k.s.* - goserelinum acetat - vefjalyf í áfylltri sprautu - 10,8 mg
harmonet tafla 75 míkróg+ 20 míkróg
pfizer aps (p) - gestodenum inn; ethinylestradiolum inn - tafla - 75 míkróg+ 20 míkróg
desirett (desogestrel) filmuhúðuð tafla 75 míkróg
exeltis healthcare s.l. - desogestrelum inn - filmuhúðuð tafla - 75 míkróg
reseligo (goserelin alvogen) vefjalyf í áfylltri sprautu 3,6 mg
alvogen ehf. - goserelinum acetat - vefjalyf í áfylltri sprautu - 3,6 mg
norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 5 mg /1,5 ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 5 mg /1,5 ml